Item 8.01. Other Events.
On October 27, 2021, Novavax, Inc. (the "Company") issued a press release
announcing completion of its rolling regulatory submission to the U.K. Medicines
and Healthcare products Regulatory Agency ("MHRA") for authorization of its
COVID-19 vaccine candidate. A copy of this press release is filed as Exhibit
99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
99.1 Press release, dated October 27, 2021, regarding the Company's
regulatory submission to the MHRA.
104 Cover Page Interactive Data File (formatted as Inline XBRL).
© Edgar Online, source Glimpses